Tollo Health

What Tollo Health does

Tollo Health, LLC is a Tampa, Florida-based medical food company that develops proprietary nutritional formulations targeting immune, metabolic, and muscle-related conditions. Its product portfolio comprises Tollovid® (a botanically-based medical food targeting the 3CL protease pathway for immune and antiviral support), Galectovid® and a specialized Galectovid® (MCAS) variant (formulations targeting Galectin-1 and Galectin-3 proteins involved in inflammation and viral replication, with the MCAS variant optimized for Mast Cell Activation Syndrome patients), CHONDROVID® (a medical food built on a proprietary micelle-forming delivery technology that enhances solubility and bioavailability of essential nutrients), and FORZET™ (powered by Myosamin™, the company's proprietary blend of proteogenic amino acids formulated to support mitochondrial biogenesis, protein synthesis, and muscle preservation, particularly for GLP-1 medication patients). The company positions its portfolio under a "food as medicine" framework, emphasizing 30+ years of underlying formulation research and products designed to be used under healthcare professional supervision.

The company sells direct-to-consumer through its owned e-commerce storefront at tollohealth.shop, with products priced on a unit basis (e.g., Tollovid pre-order at $99.50) and no subscription or prescription requirement. A second distribution layer is being built through its controlling shareholder, Wellgistics Health, whose 6,500+ pharmacy network plus the planned PharmacyChain™ blockchain-enabled delivery infrastructure and the Health Lives Here consumer app pilot launching in North Carolina in July 2026 are positioned as the primary channel for FORZET and other products targeting GLP-1 patients and Long COVID sufferers. Tollo Health also operates TolloCare, LLC, a wholly-owned subsidiary providing white-labeled telehealth services through a partner platform with more than 5,000 onboarded physicians, with mental health AI tools being integrated from a stealth San Francisco startup.

Strategically, Tollo Health is being absorbed into the broader DelivMeds AI formation with Wellgistics Health and Datavault AI, which is targeting a NASDAQ listing under ticker MEDS and approximately $4 billion in combined assets. The transaction bundles Tollo's medical food IP with QOLPOM biometric and drone delivery IP sourced from EOS Holdings and Scilex Holding Company. Leadership includes CEO Gerald Commissiong (formerly CEO of Todos Medical, Ltd. and co-founder of Amarantus Bioscience Holdings), President Reinhard Ommerborn (a life-sciences licensing lawyer and entrepreneur), CFO Daniel Hirsch (appointed April 2025), and VP Business Development Rupert Ommerborn. The company's primary end-segments are GLP-1 medication patients, Long COVID patients, aging adults, athletes, individuals with obesity and chronic metabolic conditions, and MCAS patients.

Name

Tollo Health

Legal name

Tollo Health, LLC

Website

https://www.tollohealth.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

1–10 employees

Short description

Tollo Health, LLC is a Tampa-based medical food company that develops proprietary botanical and amino-acid formulations—including Tollovid, Galectovid, Chondrovid, and FORZET—targeting immune support, viral persistence, muscle preservation during GLP-1 therapy, and chronic metabolic conditions, distributed via DTC e-commerce and through the Wellgistics pharmacy network.

Ownership category

akta.pro rank

Product category

Medical Foods

NAICS

Food (Health) Supplement Retailers (456191), Health and Personal Care Retailers (456)

akta.pro primary industry

Multivitamins & Daily Packs (CRADAGAC)

akta.pro secondary industries

Weight Management & Metabolic Supplements (CRADAGAG), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)

Keywords

• Medical foods
• Dietary supplements
• Nutritional therapeutics
• Immune support formulas
• Metabolic health products

Headquarters

HQ city

Tampa

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Medical Food Product Sales: Direct-to-consumer sales of medical food products including Tollovid, Galectovid, Chondrovid, and FORZET through owned e-commerce platform (tollohealth.shop). Products are sold as ongoing dietary supplements with repeat purchase potential.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Tollo Health develops, formulates, and sells branded medical foods and dietary supplements — Tollovid®, Galectovid®, Galectovid® MCAS, Chondrovid®, and FORZET™ — designed for the dietary management of viral persistence, long COVID, mast cell activation syndrome, and muscle preservation in GLP-1 therapy patients. Products are sold over-the-counter to consumers under healthcare professional supervision through a direct-to-consumer e-commerce storefront and, as of 2026, through a pharmacy distribution network.

Product overview

Tollo Health is a medical food company focused on developing innovative nutritional formulations for managing specific health conditions. The product portfolio includes Tollovid® (immune support via 3CL protease targeting), Galectovid® and Galectovid® (MCAS) (targeting Galectin proteins for immune and viral support), Chondrovid® (nutrient absorption via micellar technology), and Forzet™ (muscle preservation with Myosamin for chronic conditions and GLP-1 users). These medical foods are designed to work alongside existing treatments and are used under medical supervision to address dietary deficiencies and support therapeutic goals.

Differentiator

Problem solved

Functional benefit

Brands

• Tollovid®: Botanically-based dietary supplement designed to support the immune system by targeting 3CL protease, promoting resilience and vitality.
• Galectovid®
• Chondrovid®
• FORZET™

Products and services

• Tollovid® A botanically-based dietary supplement (medical food) designed to support the immune system by targeting 3CL protease, promoting resilience and vitality. Formulated with Myosamin-derived compounds and botanicals that support immune-signalling pathways and help moderate viral replication; used by consumers under healthcare professional supervision.
• Galectovid® A medical food designed to enhance the immune system and fight viral infections by targeting Galectin-1 and Galectin-3 proteins involved in inflammation and viral replication. Contains Guar Gum, a plant-based fiber with immune-supporting properties.
• Galectovid® (MCAS) A specialized variant of Galectovid® designed for individuals with Mast Cell Activation Syndrome (MCAS). Optimized formula to minimize potential mast cell reactions while blocking key proteins involved in inflammation and immune response.
• Chondrovid® A scientifically developed medical food using proprietary micelles-forming technology to optimize nutrient absorption and enhance amino-acid utilization. Improves solubility and uptake of essential nutrients through water-soluble micellar encapsulation.
• FORZET™ A breakthrough medical food powered by the Myosamin™ proprietary amino-acid blend that enhances muscle strength, energy metabolism, and overall vitality. Boosts mitochondrial biogenesis and protein synthesis; designed to combat chronic conditions and muscle loss, particularly beneficial for GLP-1 therapy patients.

Segments7 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• Wellgistics HealthcoreStrategic or Co-development Partner · 20 May 2026Wellgistics Health holds a controlling stake in Tollo Health as part of the DelivMeds AI formation. The partnership integrates Tollo Health's medical foods portfolio (Forzet and Tollovid targeting GLP-1 muscle loss and chronic viral conditions) with Wellgistics' network of 6,500+ pharmacies. The new combined entity will be listed on NASDAQ as MEDS with combined asset value of approximately $4 billion.
• TolloCare, LLCcoreTechnology or Integration · 11 February 2026TolloCare is a wholly-owned subsidiary of Tollo Health providing white-labeled telehealth services. The subsidiary has partnered with a telemedicine platform with over 5,000 onboarded physicians and a stealth San Francisco Bay Area startup for mental health AI tools. TolloCare services are being integrated with Wellgistics Pharmacy's GLP-1 prescription drug dispensing to drive patient compliance.
• Telemedicine Platform with 5,000+ PhysicianscoreChannel Partner/ Reseller/ Distributor · 11 February 2026White-labeled telemedicine platform contracted by TolloCare to provide telehealth services for GLP-1 and Long COVID patients through over 5,000 onboarded physicians nationwide.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Standard Process: Whole-food supplement and medical-nutrition company distributed primarily through healthcare practitioners. Comparable to Tollo in disease-targeted nutrition positioning and practitioner/pharmacy GTM.
• Designs for Health: Practitioner-grade supplement and medical-nutrition brand distributed through healthcare providers. Comparable to Tollo in product format (condition-specific nutrition), practitioner-channel GTM, and metabolic/immune-support positioning.
• Kate Farms: Medical nutrition company selling plant-based formulas for chronic and acute conditions via pharmacy and healthcare channels. Comparable to Tollo as a condition-specific medical-food brand targeting metabolic and immune indications with clinician-driven distribution.
• Metagenics: Practitioner-channel medical-food and supplement company selling condition-specific nutritional formulas through healthcare professionals. Closely comparable to Tollo in go-to-market (practitioner/pharmacy recommendation), disease-targeted formulations, and premium positioning.

Broad incumbents

• Nestlé Health Science: Global medical nutrition and consumer health division of Nestlé operating brands such as Garden of Life and Nature's Bounty. Directly comparable to Tollo as a medical-food / targeted-nutrition brand portfolio selling into pharmacy, practitioner, and consumer channels across metabolic, immune, and muscle-health indications.
• Abbott Nutrition: Abbott's nutrition division markets Ensure, Glucerna, and other medical foods for chronic conditions and metabolic health. Directly comparable to Tollo in medical-food formulation, disease-targeted nutrition positioning, and pharmacy distribution.
• Danone Nutricia: Danone's medical nutrition arm produces disease-specific foods (e.g., for cancer, dementia, malnutrition). Comparable to Tollo as an incumbent medical-food brand serving patients under healthcare-professional supervision with condition-specific formulations.

Emerging players

• Ritual: DTC subscription supplement brand with clinically-backed formulations and a focus on traceability/transparency. Comparable to Tollo in DTC e-commerce GTM, premium pricing, and supplement/medical-food category.
• Pendulum: DTC metabolic-health company selling clinically-studied probiotics and glucose-management supplements. Comparable to Tollo in metabolic-health positioning, mechanism-based claims (GLP-1/microbiome), and DTC subscription model.
• AG1 (Athletic Greens): High-growth DTC daily-nutrition brand with subscription e-commerce and broad metabolic/immune positioning. Comparable to Tollo in DTC marketing model, premium price point, and consumer nutritional health category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/TolloHealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tollo Health